News

Karuna Therapeutics, Inc. a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological…
Read More...

Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a strategic commercialization arrangement for rimegepant in markets outside of the United States upon approval.…
Read More...

REGENXBIO Inc. announced the closing of its Collaboration and License Agreement with AbbVie to develop and commercialize RGX-314, a potential one-time gene therapy for the treatment of…
Read More...

Eton Pharmaceuticals, Inc and Azurity Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved EPRONTIA (topiramate) oral solution, 25mg/mL.…
Read More...

Profounda, Inc. ("Profounda") announced that it has received the US Food and Drug Administration's Orphan Drug Designation Approval for the use of miltefosine to treat Invasive…
Read More...

Merck known as MSD outside the United States and Canada, today announced that its pending acquisition of Acceleron Pharma Inc. (Nasdaq: XLRN) has been cleared by the competition…
Read More...

Azurity Pharmaceuticals, Inc. a private specialty pharmaceutical company focused on developing innovative products to meet the unique needs of patients with underserved conditions,…
Read More...

EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today announced that Swissmedic has approved Bronchitol…
Read More...

Ocugen, Inc. a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced today that it has submitted a request to the…
Read More...

Green Circle Life, provider of an all-in-one communication and engagement platform SmartFHR, has launched the Covid Passport, their end-to-end solution to help employers comply with an…
Read More...

ACTICOR BIOTECH, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, announces that the U.S Food and Drug Administration (FDA) has provided…
Read More...

NRx Pharmaceuticals a clinical-stage biopharmaceutical company (NRx), today announced that the US Food and Drug Administration (FDA) has declined to issue an Emergency Use Authorization…
Read More...

Yokogawa Electric Corporation  announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess…
Read More...

Moderna Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Metagenomi, Inc., a genetic medicines company with a versatile portfolio of…
Read More...

Dunad Therapeutics ("Dunad"), a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies, announces that it has entered a…
Read More...

Venatorx Pharmaceuticals announced that it has entered into a Research Collaboration and License Agreement with Roche to discover, characterize and develop new small molecule inhibitors…
Read More...

Resverlogix Corp. a world leader in epigenetics or gene regulation, is pleased to announce that it is in active discussions with the Kingdom of Morocco’s Ministry of Health for possible…
Read More...

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the completion of its rolling…
Read More...

WuXi Biologics a global company with leading open-access biologics technology platforms, announced it has successfully launched the GMP operation of its new drug product facility…
Read More...

Ubiquigent Limited announces the extension and expansion of its long-term collaboration with Bristol Myers Squibb. Under the terms of the agreement, Ubiquigent will provide Bristol…
Read More...